Literature DB >> 2940981

Relationships between C3b receptor (CR1) activity of erythrocytes and positive Coombs' tests.

Y Inada, M Kamiyama, T Kanemitsu, W S Clark, Y Asai.   

Abstract

Although positive direct Coombs' tests occur in most patients with active systemic lupus erythematosus (SLE), haemolytic anaemic associated with antibody to erythrocytes (E) occurs in less than 10%. Our studies show an association between positive direct Coombs' tests and both the presence of circulating immune complexes and diminished activity of the C3b receptor (CR1) of E. Data presented in this report suggest that in vivo binding of immune complexes and complement by the CR1 of E results in positive direct Coombs' tests in the absence of antibody to E. These observations explain the low frequency of haemolytic anaemia compared with the high frequency of direct positive Coombs' tests in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940981      PMCID: PMC1001893          DOI: 10.1136/ard.45.5.367

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  A study of the properties of the Rhesus antibody (Ri) diagnostic for the rheumatoid factor and its application to Gm grouping.

Authors:  M WALLER; S D LAWLER
Journal:  Vox Sang       Date:  1962 Sep-Oct       Impact factor: 2.144

2.  A new elution technique for the preparation of specific immune anti-Rh serum.

Authors:  G A KELSALL; G H VOS
Journal:  Br J Haematol       Date:  1956-10       Impact factor: 6.998

3.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

4.  Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.

Authors:  M E Medof; J J Oger; J P Antel; G M Prince
Journal:  J Clin Lab Immunol       Date:  1982-02

5.  Effect of C3b inactivator on monocyte-bound C3-coated human erythrocytes.

Authors:  A D Schreiber; P B McDermott
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

6.  Action of the C3b-inactivator on the cell-bound C3b.

Authors:  S K Law; D T Fearon; R P Levine
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

7.  Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and membrane osmotic fragility.

Authors:  Y Inada; M Kamiyama; T Kanemitsu; W S Clark
Journal:  J Clin Lab Immunol       Date:  1983-10

8.  Detection of circulating immune complexes: a new application of immune adherence haemagglutination.

Authors:  Y Inada; M Kamiyama; T Kanemitsu; W S Clark
Journal:  Ann Immunol (Paris)       Date:  1981 Mar-Apr

9.  Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.

Authors:  M E Medof; G M Prince; C Mold
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

10.  Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.

Authors:  Y Inada; M Kamiyama; T Kanemitsu; C L Hyman; W S Clark
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

View more
  2 in total

1.  In vivo binding of circulating immune complexes by C3b receptors (CR1) of transfused erythrocytes.

Authors:  Y Inada; M Kamiyama; T Kanemitsu; H Ikegami; K Watanabe; W S Clark; Y Asai
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

2.  Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.

Authors:  Ekemini A Ogbu; Shanmuganathan Chandrakasan; Kelly Rouster-Stevens; Larry A Greenbaum; Ignacio Sanz; Scott E Gillespie; Chelsea Marion; Karli Okeson; Sampath Prahalad
Journal:  Lupus       Date:  2020-10-27       Impact factor: 2.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.